Cargando…
Differences between intravenous iron products: focus on treatment of iron deficiency in chronic heart failure patients
Iron deficiency is the leading cause of anaemia and is highly prevalent in patients with chronic heart failure (CHF). Iron deficiency, with or without anaemia, can be corrected with intravenous (i.v.) iron therapy. In heart failure patients, iron status screening, diagnosis, and treatment of iron de...
Autores principales: | Martin‐Malo, Alejandro, Borchard, Gerrit, Flühmann, Beat, Mori, Claudio, Silverberg, Donald, Jankowska, Ewa A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437426/ https://www.ncbi.nlm.nih.gov/pubmed/30694615 http://dx.doi.org/10.1002/ehf2.12400 |
Ejemplares similares
-
Iron Therapy in Patients with Heart Failure and Iron Deficiency: Review of Iron Preparations for Practitioners
por: Drozd, Marcin, et al.
Publicado: (2016) -
Iron Deficiency in Heart Failure: A Korea-Oriented Review
por: Jankowska, Ewa A., et al.
Publicado: (2023) -
Iron Deficiency and Deranged Myocardial Energetics in Heart Failure
por: Tkaczyszyn, Michał, et al.
Publicado: (2022) -
Is Correction of Iron Deficiency a New Addition to the Treatment of the Heart Failure?
por: Silverberg, Donald S., et al.
Publicado: (2015) -
Criticality of Surface Characteristics of Intravenous Iron–Carbohydrate Nanoparticle Complexes: Implications for Pharmacokinetics and Pharmacodynamics
por: Funk, Felix, et al.
Publicado: (2022)